Cart
sales@molnova.com
GSK-3 Inhibitor XIII
CAS No. 404828-14-4
GSK-3 Inhibitor XIII( —— )
Catalog No. M37201 CAS No. 404828-14-4
GSK-3 Inhibitor XIII, an ATP-competitive GSK-3 inhibitor (Ki: 24 nM), can be used to study diabetes and obesity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 187 | Get Quote |
|
| 5MG | 242 | Get Quote |
|
| 10MG | 436 | Get Quote |
|
| 25MG | 904 | Get Quote |
|
| 50MG | 1242 | Get Quote |
|
| 100MG | 1638 | Get Quote |
|
| 200MG | 2214 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGSK-3 Inhibitor XIII
-
NoteResearch use only, not for human use.
-
Brief DescriptionGSK-3 Inhibitor XIII, an ATP-competitive GSK-3 inhibitor (Ki: 24 nM), can be used to study diabetes and obesity.
-
DescriptionGSK-3 Inhibitor XIII is a potent and ATP-competitive GSK-3 inhibitor with a Ki of 24 nM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayPI3K/Akt/mTOR signaling
-
TargetGSK-3
-
RecptorGSK-3
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number404828-14-4
-
Formula Weight301.35
-
Molecular FormulaC18H15N5
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (331.84 mM; Ultrasonic )
-
SMILESN=1NC(=CC1NC=2N=C(N=C3C=CC=CC32)C=4C=CC=CC4)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Albert C Pierce, et al. CH...O and CH...N hydrogen bonds in ligand design: a novel quinazolin-4-ylthiazol-2-ylamine protein kinase inhibitor. J Med Chem. 2005 Feb 24;48(4):1278-81. ?
molnova catalog
related products
-
GS87
GS87 is a highly specific inhibitor of GSK3 (glycogen synthase kinase 3) that induces extensive differentiation of AML cells.GS87 potently inhibits growth of AML cells in mice with little effect on normal bone marrow cells. GS87 causes terminal differentiation of AML cells.
-
CHIR-99021 monohydro...
A potent, specific GSK-3 inhibitor with IC50 of 5 nM and 10 nM for GSK3β and GSK3α, respectively.
-
AZD2858
AZD2858 is a selective GSK-3 inhibitor with an IC50 of 68 nM, inhibits tau phosphorylation at the S396 site, activates Wnt signaling pathway.
